The AEgis Technologies Group Announces the Release of acslXpress Version 2.3 Software

Sunday, 28 Jan 2007 · Biotechnology

acslXpress is software for execution and analysis of simulations created using acslXtreme®, a sophisticated tool for modeling and simulation of continuous dynamic systems and processes. By using pre-built simulations, acslXpress provides all the advanced analytical capability of acslXtreme at a fraction of the cost. acslXtreme is used extensively in the aerospace, toxicology, pharmacology, industrial process and automotive communities. (PRWeb Jan 25, 2007) Post Comment:Trackback URL: http://www.prweb.com/chachingpr.php/SGFsZi1aZXRhLUVtcHQtWmV0YS1NYWduLVplcm8= Read More »

Also:

The AEgis Technologies Group Announces the Release of the Microsoft Excel Add-in for acslXtreme
What Research Needs, ACD/Labs Delivers with Their New Version Release
StemSoft Software Pleased to Release StemLabTM Version 3.2
PREMIER Biosoft Releases Version 4 of AlleleID with Support for Splice Variant Microarrays
Leapfrog Announces New Partner Member: USC Consulting Group

del.icio.us · digg it · link

	Vitalea Science Expands its Scientific Advisory Board, Expands Microdosing to Environmental Fate and Metabolism of Agricultural and Industrial Chemicals
	Technology Transfer Firm Partners with Local Alternative Energy Venture to Speed Commercialization: Innovation Management Partners, LLC Invests in Cleveland-based CleanFlo Technologies, LLC to Accelerate Technology Commercialization in the Growth Market for Alternative Fuels
	The AEgis Technologies Group Announces the Release of the Microsoft Excel Add-in for acslXtreme
	Monebo Technologies Obtains FDA Clearance to Market the CardioBeltâ„¢ Wireless ECG System
	Five Japanese Pharmaceutical Companies License Ariadne Pathway Studio Enterprise
	Alaska's Natural/Wild Food, Beverage and Bio Products Join Together to Stage Marketplace for Restaurant, Grocery and Food Service Market Buyers
	Akaza Research, SemanticBits and Robert H. Lurie Comprehensive Cancer Center of Northwestern University Partner to Develop caBIGâ„¢ Clinical Trials Adverse Events Reporting System for NIH's National Cancer Institute
	Amorcyte Cardiac Cell Therapy Trial Completes Second of Four Phases
	Vitalea Science Announces Key Addition to its Scientific Advisory Board in Microdosing for Pediatric Pharmacology and HIV Research
	Arrowhead Publishers' New Study Reveals Trends in Pharmaceutical Clinical Trial Outsourcing to Emerging Markets

	Biotechnology
	Electronics
	General
	Graphic Design & Printing
	Industrial
	Information Technology
	Instrumentation
	Multimedia
	Nanotechnology
	Public Sector
	Robotics
	Semiconductors
	Telecommunications